‘Innovative’ PKU treatment launched in UK
PKU is a rare, inherited metabolic disorder that affects approximately 70 babies each year in the UK.
Read More
Tag: amino acids
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
